News
Patients with severe aortic stenosis at low surgical risk who underwent supra-annular, self-expanding Evolut transcatheter aortic valve replacement (TAVR) had similar rates of death or disabling ...
11d
Asian News International on MSNHeart Valve Replaced Without Surgery Through Arm Artery - First Ever Percutaneous Trans-Axillary TAVI in IndiaFor the first time in India, doctors at Rajasthan Hospital, Jaipur have successfully replaced a heart valve through the ...
Edwards Lifesciences announced the FDA approved its transcatheter aortic valve replacement platform for treatment of severe asymptomatic aortic stenosis, the first in this patient population ...
After propensity-score adjustment, mean patient age was 67.4 years, about one-third were female, and more than one-quarter were classified as NYHA III/IV at baseline. Over 8 years, there were no ...
The PROTECTED TAVR trial investigated the use of CEP to prevent stroke related to transcatheter aortic-valve replacement ... age of the participants was 81.2±6.5 years, and 38.7% were women.
Published last year in the New England Journal of Medicine and reported by TCTMD at that time, the study showed that treating patients who had severe aortic stenosis but no symptoms with TAVI halved ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results